Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert D'Haens

Showing results (11-20 of 269) with videos related to

Pageof 27
Sort By:
Nature Reviews. Gastroenterology & Hepatology|September 2, 2016
Acute severe ulcerative colitis: from pathophysiology to clinical managementPieter Hindryckx, Vipul Jairath, Geert D'Haens
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Biosimilars for inflammatory bowel disease: how can healthcare professionals help address patients' concerns?Krisztina B Gecse, Fraser Cumming, Geert D'Haens
Inflammatory Bowel Diseases|February 21, 2018
Combination Immunosuppression in IBDSteven Bots, Krisztina Gecse, Murray Barclay, et al.
Inflammatory Intestinal Diseases|October 30, 2023
Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of InductionGeert D'Haens, Ekaterina Safroneeva, Helen Thorne, et al.
Expert Opinion on Biological Therapy|April 3, 2023
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?Suzanne I Anjie, Melanie S Hulshoff, Geert D'Haens
Inflammatory Bowel Diseases|July 12, 2025
Endoscopic Recurrence in Crohn's Disease Patients With Long-Term IleostomyLotte Oldenburg, Brecht Hens, Maxime Hollenberg, et al.
Nature Reviews. Gastroenterology & Hepatology|September 4, 2020
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?Marjorie Argollo, Paulo Gustavo Kotze, Pradeep Kakkadasam, et al.
Frontiers in Medicine|February 1, 2021
Characterization of Mucosal Lesions in Crohn's Disease Scored With Capsule Endoscopy: A Systematic ReviewMiquel Marquès Camí, Alba Serracarbasa, Geert D'Haens, et al.
Expert Review of Clinical Immunology|April 28, 2022
Emerging therapies for ulcerative colitisJurij Hanzel, Melanie S Hulshoff, Joep Grootjans, et al.
Inflammatory Bowel Diseases|January 24, 2018
Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label StudyAaron Yarlas, Geert D'Haens, Mary Kaye Willian, et al.
Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
Nature Reviews. Gastroenterology & Hepatology|September 2, 2016
Acute severe ulcerative colitis: from pathophysiology to clinical managementPieter Hindryckx, Vipul Jairath, Geert D'Haens
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Biosimilars for inflammatory bowel disease: how can healthcare professionals help address patients' concerns?Krisztina B Gecse, Fraser Cumming, Geert D'Haens
Inflammatory Bowel Diseases|February 21, 2018
Combination Immunosuppression in IBDSteven Bots, Krisztina Gecse, Murray Barclay, et al.
Inflammatory Intestinal Diseases|October 30, 2023
Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of InductionGeert D'Haens, Ekaterina Safroneeva, Helen Thorne, et al.
Expert Opinion on Biological Therapy|April 3, 2023
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?Suzanne I Anjie, Melanie S Hulshoff, Geert D'Haens
Inflammatory Bowel Diseases|July 12, 2025
Endoscopic Recurrence in Crohn's Disease Patients With Long-Term IleostomyLotte Oldenburg, Brecht Hens, Maxime Hollenberg, et al.
Nature Reviews. Gastroenterology & Hepatology|September 4, 2020
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?Marjorie Argollo, Paulo Gustavo Kotze, Pradeep Kakkadasam, et al.
Frontiers in Medicine|February 1, 2021
Characterization of Mucosal Lesions in Crohn's Disease Scored With Capsule Endoscopy: A Systematic ReviewMiquel Marquès Camí, Alba Serracarbasa, Geert D'Haens, et al.
Expert Review of Clinical Immunology|April 28, 2022
Emerging therapies for ulcerative colitisJurij Hanzel, Melanie S Hulshoff, Joep Grootjans, et al.
Inflammatory Bowel Diseases|January 24, 2018
Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label StudyAaron Yarlas, Geert D'Haens, Mary Kaye Willian, et al.
Pageof 27